Effect of IGFIR protein expression on benefit to adjuvant trastuzumab in early-stage HER2+ breast cancer in NCCTG N9831 trial
- Citation:
- J Clin Oncol vol 29 (suppl) abstr 10503
- Meeting Instance:
- ASCO 2011
- Year:
- 2011
- Type:
- Abstract
- Sub type:
- Poster General
- Funding:
- NCTN
- Endpoint:
- Secondary
- Analysis:
- Primary
- Data Sharing:
- No-Data-Sharing
- Status:
- Presented/Published
- Citation Status:
- pub
- Note:
- Methodological:
- No
- Biospecimen:
- No
- SDC:
- No
- Parents:
- None
- Children:
- 2841
- Pharmas:
- Grants:
- Corr. Author:
- Authors:
- M. M. Reinholz A. L. Dueck B. Chen X. Geiger A. Mccullough R. Jenkins W. Lingle C. Andorfer N. Davidson S. Martino P. Kaufman L. Kutteh G. Sledge L. Harris J. Gralow E. Perez
- Networks:
- Study
- NCCTG-N9831
- Multiple Studies, or Legacy Studies in Alliance Study:
- Phases:
- 3
- Keywords: